Used primarily as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system (CNS) active agents. Its structure supports the incorporation of fluorine, which enhances metabolic stability and bioavailability in drug candidates. Commonly employed in medicinal chemistry for constructing beta-amino alcohol motifs found in bioactive molecules. Also utilized in the preparation of radiolabeled compounds for positron emission tomography (PET) imaging due to the presence of fluorine, enabling direct labeling with fluorine-18. Plays a role in the development of novel antidepressants and anxiolytic drugs through rational drug design.